Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Association studies of ALOX5 and bone mineral density in healthy adults.

Foroud T, Ichikawa S, Koller D, Lai D, Curry L, Xuei X, Edenberg HJ, Hui S, Peacock M, Econs MJ.

Osteoporos Int. 2008 May;19(5):637-43.

2.

A chromosomal inversion within a quantitative trait locus has a major effect on adipogenesis and osteoblastogenesis.

Ackert-Bicknell CL, Salisbury JL, Horowitz M, DeMambro VE, Horton LG, Shultz KL, Lecka-Czernik B, Rosen CJ.

Ann N Y Acad Sci. 2007 Nov;1116:291-305.

PMID:
17584978
3.

Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone.

Lazarenko OP, Rzonca SO, Hogue WR, Swain FL, Suva LJ, Lecka-Czernik B.

Endocrinology. 2007 Jun;148(6):2669-80.

4.

Resolving the Two "Bony" Faces of PPAR-gamma.

Lecka-Czernik B, Suva LJ.

PPAR Res. 2006;2006:27489.

5.

Meta-analysis of genome-wide scans provides evidence for sex- and site-specific regulation of bone mass.

Ioannidis JP, Ng MY, Sham PC, Zintzaras E, Lewis CM, Deng HW, Econs MJ, Karasik D, Devoto M, Kammerer CM, Spector T, Andrew T, Cupples LA, Duncan EL, Foroud T, Kiel DP, Koller D, Langdahl B, Mitchell BD, Peacock M, Recker R, Shen H, Sol-Church K, Spotila LD, Uitterlinden AG, Wilson SG, Kung AW, Ralston SH.

J Bone Miner Res. 2007 Feb;22(2):173-83.

6.

Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells.

Crossno JT Jr, Majka SM, Grazia T, Gill RG, Klemm DJ.

J Clin Invest. 2006 Dec;116(12):3220-8.

7.

Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo.

Lecka-Czernik B, Ackert-Bicknell C, Adamo ML, Marmolejos V, Churchill GA, Shockley KR, Reid IR, Grey A, Rosen CJ.

Endocrinology. 2007 Feb;148(2):903-11.

8.

Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function.

Abdelmagid SM, Barbe MF, Arango-Hisijara I, Owen TA, Popoff SN, Safadi FF.

J Cell Physiol. 2007 Jan;210(1):26-37.

PMID:
17034042
9.

Individual single tube genotyping and DNA pooling by allele-specific PCR to uncover associations of polymorphisms with complex diseases.

Casado-Díaz A, Cuenca-Acevedo R, Quesada JM, Dorado G.

Clin Chim Acta. 2007 Feb;376(1-2):155-62.

PMID:
16999948
10.

Genetic regulation of bone mass and susceptibility to osteoporosis.

Ralston SH, de Crombrugghe B.

Genes Dev. 2006 Sep 15;20(18):2492-506. Review.

11.

Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage.

Davidson RK, Waters JG, Kevorkian L, Darrah C, Cooper A, Donell ST, Clark IM.

Arthritis Res Ther. 2006;8(4):R124.

12.

Recent advances in the genetics of osteoporosis.

Williams FM, Spector TD.

J Musculoskelet Neuronal Interact. 2006 Jan-Mar;6(1):27-35. Review.

13.

Congenic mice provide in vivo evidence for a genetic locus that modulates serum insulin-like growth factor-I and bone acquisition.

Delahunty KM, Shultz KL, Gronowicz GA, Koczon-Jaremko B, Adamo ML, Horton LG, Lorenzo J, Donahue LR, Ackert-Bicknell C, Kream BE, Beamer WG, Rosen CJ.

Endocrinology. 2006 Aug;147(8):3915-23.

PMID:
16675518
14.

Arachidonate 5-lipoxygenase variants in atherosclerosis, obesity, and bone traits.

Lyons MA.

Circ Res. 2006 Apr 28;98(8):e66. No abstract available.

15.
16.

Meta-analysis of genome-wide linkage studies for bone mineral density.

Lee YH, Rho YH, Choi SJ, Ji JD, Song GG.

J Hum Genet. 2006;51(5):480-6.

PMID:
16534542
17.

Dietary saturated fat intake is inversely associated with bone density in humans: analysis of NHANES III.

Corwin RL, Hartman TJ, Maczuga SA, Graubard BI.

J Nutr. 2006 Jan;136(1):159-65.

18.

Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits.

Mehrabian M, Allayee H, Stockton J, Lum PY, Drake TA, Castellani LW, Suh M, Armour C, Edwards S, Lamb J, Lusis AJ, Schadt EE.

Nat Genet. 2005 Nov;37(11):1224-33. Erratum in: Nat Genet. 2005 Dec;37(12):1381.

PMID:
16200066
19.

Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice.

Inoue M, Ohtake T, Motomura W, Takahashi N, Hosoki Y, Miyoshi S, Suzuki Y, Saito H, Kohgo Y, Okumura T.

Biochem Biophys Res Commun. 2005 Oct 14;336(1):215-22.

PMID:
16125673
20.
Items per page

Supplemental Content

Support Center